Home › Stocks › NGM › All Fund Holders
NGM — NGM BIOPHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 36 · Reported value held: $12.62M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q1 2024 | 2.32M | $3.70M | 0.00% | Reduce |
| Marshall Wace history | Q3 2021 | 86.03K | $1.81M | 0.01% | New |
| Geode Capital Management history | Q1 2024 | 983.84K | $1.56M | 0.00% | Add |
| Arrowstreet Capital history | Q3 2022 | 51.86K | $678.00K | 0.00% | Add |
| Northern Trust Corp history | Q1 2024 | 372.73K | $592.65K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2024 | 360.60K | $573.35K | 0.00% | New |
| Citadel Advisors history | Q1 2024 | 343.19K | $545.68K | 0.00% | Add |
| Charles Schwab Investment Management history | Q1 2024 | 284.65K | $452.59K | 0.00% | Add |
| Wellington Management Group history | Q2 2022 | 27.00K | $346.00K | 0.00% | Hold |
| Goldman Sachs Group history | Q1 2024 | 209.30K | $332.78K | 0.00% | Add |
| D. E. Shaw & Co history | Q4 2023 | 308.10K | $264.66K | 0.00% | Reduce |
| Morgan Stanley history | Q1 2024 | 155.46K | $247.19K | 0.00% | Reduce |
| BNY Mellon history | Q1 2024 | 133.22K | $211.83K | 0.00% | Reduce |
| Deutsche Bank AG history | Q4 2023 | 212.94K | $183.13K | 0.00% | New |
| Citigroup Inc history | Q1 2024 | 107.48K | $170.90K | 0.00% | Add |
| CPP Investments history | Q4 2021 | 9.00K | $159.00K | 0.00% | New |
| Millennium Management history | Q1 2024 | 66.18K | $105.23K | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2023 | 23.12K | $94.31K | 0.00% | New |
| Amundi US history | Q3 2022 | 7.41K | $93.00K | 0.00% | Hold |
| UBS Group AG history | Q1 2024 | 45.44K | $72.24K | 0.00% | Reduce |
| Manulife Financial history | Q1 2023 | 17.51K | $71.43K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q1 2024 | 35.06K | $55.75K | 0.00% | Reduce |
| Two Sigma Investments history | Q1 2024 | 27.80K | $44.20K | 0.00% | Reduce |
| Bank of America Corp history | Q1 2024 | 25.72K | $40.90K | 0.00% | Reduce |
| Janus Henderson Group history | Q2 2023 | 13.10K | $33.85K | 0.00% | Add |
| Principal Global Investors history | Q1 2024 | 19.80K | $31.48K | 0.00% | Add |
| JPMorgan Chase & Co history | Q1 2024 | 18.50K | $29.41K | 0.00% | Reduce |
| AQR Capital Management history | Q1 2024 | 16.96K | $26.97K | 0.00% | New |
| Prudential Financial history | Q4 2023 | 29.79K | $25.59K | 0.00% | New |
| Wells Fargo & Co history | Q1 2024 | 15.41K | $24.50K | 0.00% | Add |
| Invesco Ltd history | Q1 2024 | 12.94K | $20.57K | 0.00% | Reduce |
| Franklin Resources history | Q3 2023 | 14.10K | $15.09K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2024 | 3.03K | $4.82K | 0.00% | Hold |
| Renaissance Technologies history | Q1 2024 | 611.30K | $972 | 0.00% | Reduce |
| PNC Financial Services history | Q3 2023 | 512 | $548 | 0.00% | Reduce |
| T. Rowe Price Associates history | Q1 2024 | 10.87K | $18 | 0.00% | Add |